CAS: 1123837-84-2 - N-[3-Fluoro-4-[[2-[5-[[(2-methoxyethyl)amino]methyl]-2-pyridinyl]thieno[3,2-b]pyridin-7-yl]oxy]phenyl]-N′-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide
Fórmula:C33H29F2N5O4S
InChI:InChI=1S/C33H29F2N5O4S/c1-43-15-14-36-18-20-2-8-25(38-19-20)29-17-26-30(45-29)28(10-13-37-26)44-27-9-7-23(16-24(27)35)40-32(42)33(11-12-33)31(41)39-22-5-3-21(34)4-6-22/h2-10,13,16-17,19,36H,11-12,14-15,18H2,1H3,(H,39,41)(H,40,42)
Chave InChI:InChIKey=WLAVZAAODLTUSW-UHFFFAOYSA-N
SMILES:O=C(NC1=CC=C(F)C=C1)C2(C(=O)NC3=CC=C(OC=4C=CN=C5C=C(SC54)C=6N=CC(=CC6)CNCCOC)C(F)=C3)CC2
- Sinónimos:
- MGCD 516
- N-[3-Fluoro-4-[[2-[5-[[(2-methoxyethyl)amino]methyl]-2-pyridinyl]thieno[3,2-b]pyridin-7-yl]oxy]phenyl]-N′-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide
- N-(3-fluoro-4-{[2-(5-{[(2-methoxyethyl)amino]methyl}pyridin-2-yl)thieno[3,2-b]pyridin-7-yl]oxy}phenyl)-N′-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
- 1,1-Cyclopropanedicarboxamide, N-[3-fluoro-4-[[2-[5-[[(2-methoxyethyl)amino]methyl]-2-pyridinyl]thieno[3,2-b]pyridin-7-yl]oxy]phenyl]-N′-(4-fluorophenyl)-
- Sitravatinib
Marca | Dados do produto | Pureza | Gama de preços | Estimativa de entrega |
---|---|---|---|---|
Sitravatinib REF: IN-DA008TPJCAS: 1123837-84-2 | 98% | A consultar | Ter 07 Jan 25 | |
Sitravatinib REF: TM-T4349CAS: 1123837-84-2 | 98.9% - 99.74% | 51,00 €~829,00 € | Ter 14 Jan 25 | |
Sitravatinib REF: 3D-BS166446CAS: 1123837-84-2 | Min. 95% | 190,00 €~553,00 € | Qui 16 Jan 25 | |
MGCD 516 REF: TR-M340970CAS: 1123837-84-2 | - - - | 13.287,00 € | Ter 18 Fev 25 |
Ref: IN-DA008TPJ
10mg | 129,00 € | ||
25mg | 181,00 € | ||
50mg | 287,00 € | ||
100mg | 610,00 € |
Sitravatinib
Ref: TM-T4349
5mg | 51,00 € | ||
10mg | 78,00 € | ||
25mg | 134,00 € | ||
50mg | 206,00 € | ||
100mg | 330,00 € | ||
200mg | 523,00 € | ||
500mg | 829,00 € | ||
1mL*10mM (DMSO) | 72,00 € |
Sitravatinib
Ref: 3D-BS166446
5mg | 190,00 € | ||
10mg | 262,00 € | ||
50mg | 553,00 € |
MGCD 516
Produto ControladoRef: TR-M340970
1g | 13.287,00 € |